Literature DB >> 22439070

The impact of preeclampsia in pregnancy.

Aferdita Manaj1, Arben Rrugia, Nikita Manoku.   

Abstract

Objective. To observe the influence of preeclampsia during pregnancy. Materials and methods. 5711 patient's records of the year 2008 and 6188 patient's records of the year 2009 of Obstetric/Gynecologic hospital 'Queen Geraldina' have been consulted. The age of women that we studied in 2008 was between 23-35 and in 2009 was be-tween 25-34 years old. We have made a careful diagnose of inducted hypertension of pregnancy and preeclampsia. Results. The incidence of preeclampsia in the population was 4.1% (n =238) in 2008 and 3.1% (n=192) in 2009.The incidence of the cases that developed from preeclampsia to eclampsia were respectively 1.6% (n=4) and 1.5% (n=3) on 2009. Babies which have preeclamptic mothers were preterm in 13% (n=31) of cases, and 14.5% (n=28) of which have severe hypotrophia vs. 10% (n=24) and 11% (n=21) severe hypotrophia in 2009. Babies mortality on the preeclamptic population were respectively 8% (n=19) and 7.8% (n=15). Conclusions. From the survey resulted that patients diagnosed with preeclampsia manifested on a high rate hypertension and proteinuria. Prematurity, severe hypotrophy and baby's mortality were the major complications of preeclampsia. Women with preeclampsia were especially the youngest.

Entities:  

Keywords:  babies mortality; hypotrophy; preeclampsia; uterin artery Doppler

Year:  2011        PMID: 22439070      PMCID: PMC3279149     

Source DB:  PubMed          Journal:  J Prenat Med        ISSN: 1971-3282


  17 in total

1.  Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network.

Authors:  I M Bernstein; J D Horbar; G J Badger; A Ohlsson; A Golan
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

2.  The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens.

Authors:  A A Baschat; U Gembruch; C R Harman
Journal:  Ultrasound Obstet Gynecol       Date:  2001-12       Impact factor: 7.299

3.  Contemporary concepts of the pathogenesis and management of preeclampsia.

Authors:  Kristine Y Lain; James M Roberts
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

Review 4.  Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy.

Authors:  Jason J S Waugh; T Justin Clark; T G Divakaran; Khalid S Khan; Mark D Kilby
Journal:  Obstet Gynecol       Date:  2004-04       Impact factor: 7.661

5.  Abnormal endothelial cell function of resistance arteries from women with preeclampsia.

Authors:  A L McCarthy; R G Woolfson; S K Raju; L Poston
Journal:  Am J Obstet Gynecol       Date:  1993-04       Impact factor: 8.661

6.  Impact of preeclampsia and gestational hypertension on birth weight by gestational age.

Authors:  Xu Xiong; Nestor N Demianczuk; L Duncan Saunders; Fu-Lin Wang; William D Fraser
Journal:  Am J Epidemiol       Date:  2002-02-01       Impact factor: 4.897

7.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 8.  Diagnosis and management of gestational hypertension and preeclampsia.

Authors:  Baha M Sibai
Journal:  Obstet Gynecol       Date:  2003-07       Impact factor: 7.661

9.  Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis.

Authors:  B M Sibai; B Mercer; C Sarinoglu
Journal:  Am J Obstet Gynecol       Date:  1991-11       Impact factor: 8.661

Review 10.  Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count.

Authors:  Baha M Sibai
Journal:  Obstet Gynecol       Date:  2004-05       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.